![](/img/cover-not-exists.png)
Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Who Experienced Disease Progression During or After Trastuzumab-Based Therapy
Urruticoechea, Ander, Rizwanullah, Mohammed, Im, Seock-Ah, Ruiz, Antonio Carlos Sánchez, Láng, István, Tomasello, Gianluca, Douthwaite, Hannah, Badovinac Crnjevic, Tanja, Heeson, Sarah, Eng-Wong, JennVolume:
35
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2016.70.6267
Date:
September, 2017
File:
PDF, 798 KB
2017